2020
DOI: 10.3390/vaccines8040739
|View full text |Cite
|
Sign up to set email alerts
|

Efforts at COVID-19 Vaccine Development: Challenges and Successes

Abstract: The rapid spread of SARS-CoV-2, the new coronavirus (CoV), throughout the globe poses a daunting public health emergency. Different preventive efforts have been undertaken in response to this global health predicament; amongst them, vaccine development is at the forefront. Several sophisticated designs have been applied to create a vaccine against SARS-CoV-2, and 44 candidates have already entered clinical trials. At present, it is unclear which ones will meet the objectives of efficiency and safety, though se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
90
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 114 publications
(90 citation statements)
references
References 79 publications
(68 reference statements)
0
90
0
Order By: Relevance
“…For instance, there are vaccines that require special storage and transportation, and this affects the availability of the vaccine. Moreover, the current number of vaccine shots are not enough to vaccinate the whole world population [29,80,[158][159][160].…”
Section: Discussionmentioning
confidence: 99%
“…For instance, there are vaccines that require special storage and transportation, and this affects the availability of the vaccine. Moreover, the current number of vaccine shots are not enough to vaccinate the whole world population [29,80,[158][159][160].…”
Section: Discussionmentioning
confidence: 99%
“…At present, various SARS-CoV-2 vaccines with different characteristics, such as inactivated vaccine, subunit vaccine, DNA vaccine and mRNA vaccine, are under development at different stages [ 5 , 6 ]. Several vaccines have entered Phase III clinical trials, and the safety and effectiveness of these vaccines will be tested via a large-scale vaccination of subjects [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…These concerns with the unintended consequences of COVID-19, coupled with the socioeconomic consequences of COVID-19 along with growing morbidity and mortality rates, has resulted in pharmaceutical companies, governments, funding agencies worldwide investing considerable efforts and resources in accelerated research and development of vaccines as a viable future prevention measure once the gene sequence became known (30)(31)(32)(33)(34). As of 16 June 2021, there were 287 vaccine candidates, 185 in the pre-clinical phase and 102 in the clinical phase (35).…”
Section: Introductionmentioning
confidence: 99%